The Berthold Technologies group operates from the Bad Wildbad/Germany headquarter, and has affiliate companies and strong partners globally. All activities of Titertek-Berthold will be moved to the Berthold Technologies headquarter. The newly combined life science business unit will be led by Dr. Anselm Berthold, owner and president of Titertek-Berthold and shareholder of Berthold Technologies GmbH.
The products of Titertek-Berthold / Berthold Detection Systems GmbH and the life science business of Berthold Technologies GmbH & Co. KG (“Bioanalytic”) have been trusted by scientists in basic research, pharmaceutical, biomedical and applied markets laboratories across the globe for more than half a century.